Select all the dates you'd like to sign-up for and click "Sign Up"
Navigating Payer Decisions in an Evolving Multiple Myeloma Treatment Landscape: Payer Considerations on the Economic Implications of Disease Progression in MM and Appropriate Treatment Sequencing
Jointly provided by
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.